Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
PI Industries Limited (PIIND.NS)
Gurugram, IN
PI Industries Limited is a global enterprise engaged in the manufacturing and distribution of agrochemicals, with its operations spanning India, the broader Asian continent, North America, Europe, and other international markets. The company's diverse product range includes essential agrochemicals such as insecticides, fungicides, and herbicides, alongside specialty agricultural formulations and key generic molecules like profenofos, ethion, and phorate. These are primarily sold under recognized brands such as Nominee Gold, Osheen, Biovita, Cosko, Roket, Keefun, Elite, Humesol, and Awkira. Furthermore, PI Industries supplies various chemical and active intermediates. Beyond product offerings, it delivers extensive research and development (R&D) services, covering aspects from target discovery and molecule design to library synthesis, lead optimization, biological evaluation, and route synthesis. The company also excels in providing comprehensive custom synthesis and manufacturing solutions. These encompass process R&D, analytical method development, synthesis of reference standards, impurity elucidation and synthesis, physio-chemical studies with GLP-compliant 5-batch analysis, scale-up studies, safety data generation, waste classification and treatability assessments, process/plant engineering, and large-scale commercial production. Its products are brought to market through an established network of distributors, dealers, and retailers. Originally incorporated in 1946 as Mewar Oil & General Mills Ltd., PI Industries is headquartered in Gurugram, India.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.45% | +5.17% | -6.86% | -1.89% | -14.18% | -12.24% | -28.47% | -24.45% | +1.53% | +315.00% | +3,836.96% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-06 | Change |
|---|---|---|
| Strong Buy | 3 | 0 |
| Buy | 5 | 0 |
| Hold | 9 | 0 |
| Sell | 4 | 0 |
| Strong Sell | 3 | -1 |
-
Revenue growth Agricultural Inputs: +9.5%-15.1% Q1'26: -8.6% (vs Q1'25)
-
EPS growth Agricultural Inputs: +23.0%-20.4% Q1'26: -39.4% (vs Q1'25)
-
FCF margin FCF growth · Agricultural Inputs: +27.6%+5.6% Q1'26: -12.8% (vs Q1'25)
-
EBIT margin Agricultural Inputs: +9.7%+25.5% ★ Q1'26: +19.4% (vs Q1'25)
-
ROIC Agricultural Inputs: +7.4%+16.5% ★ Q1'26: +10.1% (vs Q1'25)
-
Share dilution Agricultural Inputs: +0.0%0.0% ★ Q1'26: -0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Agricultural Inputs: 0.03×0.16× ★ Q1'26: 0.21× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2012 actual |
Mar 2013 actual |
Mar 2014 actual |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 23 Rev. Ana. 23 EPS Ana. |
Mar 2027 20 Rev. Ana. 19 EPS Ana. |
Mar 2028 23 Rev. Ana. 22 EPS Ana. |
Mar 2029 11 Rev. Ana. 16 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
8.77B
est: 8.96B (-2.1%)
|
11.48B
est: 11.28B (+1.8%)
|
15.87B
est: 16.43B (-3.4%)
|
19.37B
est: 18.91B (+2.4%)
|
20.76B
est: 20.95B (-0.9%)
|
22.45B
est: 23.50B (-4.5%)
|
22.45B
est: 23.67B (-5.2%)
|
27.92B
est: 27.71B (+0.8%)
|
33.07B
est: 34.44B (-4.0%)
|
45.20B
est: 44.95B (+0.6%)
|
53.00B
est: 53.04B (-0.1%)
|
64.58B
est: 65.95B (-2.1%)
|
76.12B
est: 78.17B (-2.6%)
|
79.03B
est: 80.98B (-2.4%)
|
68.47B
64.75B – 80.43B
-15.4% YoY
|
74.40B
71.16B – 78.50B
+8.7% YoY
|
85.23B
75.20B – 105.10B
+14.6% YoY
|
98.88B
90.65B – 113.75B
+16.0% YoY
|
| EBITDA |
1.80B
est: 2.37B (-24.0%)
|
1.88B
est: 1.75B (+7.2%)
|
3.04B
est: 2.21B (+37.3%)
|
4.14B
est: 3.45B (+20.0%)
|
4.66B
est: 4.89B (-4.7%)
|
5.89B
est: 5.37B (+9.8%)
|
5.53B
est: 6.22B (-11.0%)
|
6.36B
est: 7.02B (-9.4%)
|
7.69B
est: 8.40B (-8.4%)
|
11.41B
est: 9.27B (+23.1%)
|
12.47B
est: 11.33B (+10.1%)
|
17.08B
est: 13.56B (+25.9%)
|
22.33B
est: 16.32B (+36.8%)
|
25.28B
est: 32.22B (-21.6%)
|
28.14B
26.61B – 33.06B
-12.7% YoY
|
30.57B
29.24B – 32.26B
+8.7% YoY
|
35.03B
30.91B – 43.19B
+14.6% YoY
|
40.64B
37.26B – 46.75B
+16.0% YoY
|
| EBIT |
1.62B
est: 2.01B (-19.3%)
|
1.66B
est: 1.63B (+1.4%)
|
2.72B
est: 2.31B (+18.2%)
|
3.64B
est: 3.06B (+19.1%)
|
4.12B
est: 3.70B (+11.4%)
|
5.16B
est: 4.21B (+22.7%)
|
4.71B
est: 4.89B (-3.8%)
|
5.43B
est: 4.79B (+13.2%)
|
6.33B
est: 5.98B (+5.7%)
|
9.67B
est: 7.34B (+31.7%)
|
10.46B
est: 8.97B (+16.6%)
|
14.81B
est: 10.73B (+38.0%)
|
19.25B
est: 12.91B (+49.0%)
|
21.75B
est: 25.84B (-15.8%)
|
22.56B
21.34B – 26.51B
-12.7% YoY
|
24.52B
23.45B – 25.87B
+8.7% YoY
|
28.09B
24.78B – 34.64B
+14.6% YoY
|
32.59B
29.88B – 37.49B
+16.0% YoY
|
| Net Income |
1.04B
est: 1.07B (-2.9%)
|
973.42M
est: 1.29B (-24.4%)
|
1.88B
est: 1.42B (+32.7%)
|
2.46B
est: 2.20B (+11.9%)
|
3.12B
est: 2.76B (+13.1%)
|
4.59B
est: 3.46B (+32.7%)
|
3.68B
est: 4.68B (-21.4%)
|
4.10B
est: 4.29B (-4.3%)
|
4.57B
est: 5.06B (-9.8%)
|
7.38B
est: 5.77B (+28.0%)
|
8.44B
est: 7.05B (+19.8%)
|
12.30B
est: 8.43B (+45.8%)
|
16.82B
est: 10.15B (+65.7%)
|
16.60B
est: 14.40B (+15.3%)
|
13.24B
11.91B – 16.26B
-8.0% YoY
|
13.36B
11.85B – 15.42B
+0.8% YoY
|
16.25B
12.33B – 23.47B
+21.7% YoY
|
19.34B
17.25B – 23.12B
+19.0% YoY
|
| SGA |
511.98M
est: 640.30M (-20.0%)
|
1.79B
est: 2.80B (-36.1%)
|
2.12B
est: 4.12B (-48.5%)
|
1.79B
est: 4.22B (-57.5%)
|
2.35B
est: 4.67B (-49.6%)
|
2.83B
est: 5.27B (-46.4%)
|
3.05B
est: 5.32B (-42.7%)
|
3.29B
est: 6.77B (-51.4%)
|
3.73B
est: 8.30B (-55.0%)
|
4.25B
est: 9.39B (-54.8%)
|
4.93B
est: 11.47B (-57.0%)
|
5.49B
est: 13.73B (-60.1%)
|
7.31B
est: 16.53B (-55.7%)
|
8.43B
est: 8.87B (-4.9%)
|
7.74B
7.32B – 9.10B
-12.7% YoY
|
8.41B
8.05B – 8.88B
+8.7% YoY
|
9.64B
8.50B – 11.89B
+14.6% YoY
|
11.18B
10.25B – 12.86B
+16.0% YoY
|
| EPS |
1.66
est: 7.03 (-76.4%)
|
7.65
est: 8.36 (-8.5%)
|
13.84
est: 13.42 (+3.1%)
|
18.03
est: 17.71 (+1.8%)
|
22.77
est: 22.04 (+3.3%)
|
33.46
est: 30.21 (+10.8%)
|
26.72
est: 28.99 (-7.8%)
|
29.74
est: 29.90 (-0.5%)
|
33.08
est: 35.21 (-6.1%)
|
49.92
est: 49.02 (+1.8%)
|
55.64
est: 56.91 (-2.2%)
|
81.06
est: 83.22 (-2.6%)
|
110.85
est: 106.74 (+3.8%)
|
109.44
est: 111.21 (-1.6%)
|
87.30
78.48 – 107.21
-21.5% YoY
|
88.03
78.09 – 101.65
+0.8% YoY
|
107.12
81.27 – 154.70
+21.7% YoY
|
127.47
113.68 – 152.39
+19.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-12 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-06-11 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-06-10 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-06-09 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-06-08 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-06-05 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-06-04 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-06-03 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-06-02 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-06-01 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-29 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-27 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-26 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-25 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-22 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-21 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-20 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-19 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-18 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-15 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-14 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-13 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-12 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-05 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-04 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-29 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-28 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-27 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-24 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-23 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-22 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-21 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-20 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-17 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-16 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-15 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Mayank Singhal | Executive Vice-Chairman & MD | 260M | male |
| Rajnish Sarna | Chief Investor Relations Off, President of IT & Finance and Non-Executive Non-Independent Director | 100M | male |
| Atanu Roy | Global Chief Information Officer | — | male |
| Atul Kumar Gupta | CEO & C.S.M. of PI AgSciences and Whole-time Director | — | — |
| Jagresh Rana | CEO of AgSciences & CEO of Biologicals business | — | male |
| Kamali Rajesh | Global Chief People Officer | — | female |
| Ramesh Subramanian | Global CEO of PI Health Sciences | — | — |
| Sanjay Agarwal | Group Chief Financial Officer and Head of Strategy & Integrated Development Cell | — | male |
| Amit Goel | Lead Corporate Legal | — | male |
| Shruti Joshi | Company Secretary & Compliance Officer | — | female |
| Arunabha RayChaudhuri | Global Head of Supply Chain Management | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PIIND.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
